GOLDen hour extended EVACuation (GOLDEVAC)
Closed Pre-Solicitation Posted
- Solicitation number
- HR001124S0024
- Agency
- Defense Advanced Research Projects Agency Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Points of contact
-
- Adam Willis goldevac@darpa.mil
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Advanced Research Projects Agency (DARPA) is seeking innovative proposals for intravascular gas-exchange and trauma resuscitation devices that can enable management of polytrauma patients through a single intravascular access without the thrombotic complications associated with extracorporeal membrane oxygenation. The proposed research should investigate approaches that enable revolutionary advances beyond the existing state of practice. Key requirements include demonstrating the ability to resuscitate and oxygenate a large animal model using a single cannula with an insertion diameter of 15 French or less. Abstracts are due by June 4, 2024, and DARPA will provide recommendations on whether to submit a full proposal, though a favorable response is not a guarantee of award. The program will be executed in two phases over 30 months.
This pre-solicitation notice does not use any set-aside designations. The relevant NAICS code is 339113 (Surgical Appliance and Supplies Manufacturing) and the PSC code is 6515 (Medical and Surgical Instruments, Equipment, and Supplies). DARPA plans to make multiple awards for procurement contracts, cooperative agreements, or other transactions, but no specific budget ranges or incumbent contractors are provided.
Notice text
The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals in the following technical area: intravascular gas-exchange and trauma resuscitation through a single intravascular cannula. Proposed research should investigate innovative approaches that enable revolutionary advances which would develop the necessary device(s) to enable management of a polytrauma patient through a single intravascular access without the thrombotic complications associated with extracorporeal membrane oxygenation. Specifically excluded is research that primarily results in evolutionary improvements to the existing state of practice.
Attachments
| File | Type | Posted |
|---|---|---|
| GOLDEVAC_BAA_Attachment_A_Abstract_Summary_Side_Template.pptx | PPTX presentation | |
| GOLDEVAC_BAA_Attachment_E_Proposal_Instructions_and_Volume_II_Template.docx | DOCX document | |
| GOLDEVAC_BAA_Attachment_B_Abstract_Instructions_and_Template.docx | DOCX document | |
| GOLDEVAC_BAA_Attachment_D_Proposal_Instructions_and_Volume_I_Template.docx | DOCX document | |
| GOLDEVAC_BAA_Attachment_C_Proposal_Summary_Slide_Template.pptx | PPTX presentation | |
| HR001124S0024.pdf | ||
| GOLDEVAC_BAA_Attachment_F_Cost_Proposal_Spreadsheet.xlsx | XLSX spreadsheet |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity